|
| Title |
Date |
|
ThermoGenesis Applauds the U.S. Congress for Passing the "Stem Cell Therapeutic and Research Act of 2005"
|
December 19, 2005 |
|
ThermoGenesis Corp. Announces Shelf Registration is Declared Effective
|
December 14, 2005 |
|
ThermoGenesis Corp. and Medware Information Systems, Inc. to Collaborate on First Integrated System to Manufacture Cell Therapy Products
|
December 13, 2005 |
|
ThermoGenesis and Medtronic Sign Thrombin Processing Device (TM) (TPD) Agreement
|
November 8, 2005 |
|
ThermoGenesis Corp. Selects Lazar Partners, Ltd. as Public Relations Agency
|
October 24, 2005 |
|
ThermoGenesis to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference on Tuesday, October 25, 2005
|
October 21, 2005 |
|
Dr. Masaru Shimizu Presents Multi-Center Clinical Trial Results for ThermoGenesis CryoSeal (FS) System in Japan
|
October 18, 2005 |
|
GE Healthcare and ThermoGenesis Announce Worldwide Distribution Agreement and R&D Collaboration
|
October 14, 2005 |
|
ThermoGenesis Corp. Provides Master File for the AutoXpress (TM) System to the FDA
|
October 12, 2005 |
|
ThermoGenesis Corp. to Present at the UBS Global Life Science Conference
|
September 22, 2005 |
|
ThermoGenesis Corp. to Announce Fourth Quarter and Year-End Results on September 9, 2005
|
September 8, 2005 |
|
ThermoGenesis' CryoSeal (R) Fibrin Sealant System and Thrombin Processing Device (TM) (TPD(TM)) to be Distributed in Switzerland and Ireland
|
August 29, 2005 |
|
THERMOGENESIS’ CRYOSEAL® “AUTOLOGOUS” FIBRIN SEALANT JAPANESE CLINICAL TRIAL RESULTS ACCEPTED FOR POSTER PRESENTATION AT OCTOBER 2005 AABB MEETING
|
August 9, 2005 |
|
ThermoGenesis Corp. Rejoins the Russell 3000 (R) Index and Becomes a Member of the Russell Microcap (TM) Index
|
July 5, 2005 |
|
Thermogenesis Corp. Completes enrollment of 150-Patient Human Clinical Trial of Cryoseal® Fibrin Sealant System
|
June 22, 2005 |
|
ThermoGenesis hires new Executive Director of Scientific Affairs
|
June 8, 2005 |
|
ThermoGenesis Signs Agreement With M.D. Management to Distribute The CryoSeal® Fibrin Sealant System in The Netherlands
|
May 31, 2005 |
|
ThermoGenesis Autologous Thrombin Processive (TPD) Receives CE Mark to Allow Sales in Europe
|
May 26, 2005 |
|
Stem Cell Therapeutic and Research Act of 2005 (HR-2520)
Passes The House of Representatives
|
May 25, 2005 |
|
ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.
|
April 5, 2005 |
|
ThermoGenesis Corp. Requests The U.S. Patent Office to Re-examine Two Additional PharmaStem Cord Blood Stem Cell Patents
|
March 8, 2005 |
|
ThermoGenesis Corp. and The International Netcord Foundation Report The U.S. Patent Office Has Rejected All Claims of Pharmastem Cord Blood Stem Cell Patent
|
March 1, 2005 |
|
ThermoGenesis Corp. Announces Second Quarter Results -
Record Q2 Revenues and Gross Margin Increase 18% over
Prior Year – Company Makes Key Investments in New Product Development, Clinical Trials & Compliance with Section 404 of
the Sarbanes-Oxley Act of 2002
|
February 9, 2005 |
|
ThermoGenesis Corp. to Announce 2nd Quarter Financial Results on February 9, 2005
|
February 7, 2005 |
|
ThermoGenesis’ Cryoseal® Fibrin Sealant Reduces Blood Loss
and Pain in Total Knee Arthroplasty (TKA) Study
|
January 26, 2005 |
|
|
|
